Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Ignacio García-Tuñon"'
Autor:
Sherezade Fuentes-Julián, Francisco Arnalich-Montiel, Laia Jaumandreu, Marina Leal, Alfonso Casado, Ignacio García-Tuñon, Enrique Hernández-Jiménez, Eduardo López-Collazo, Maria P De Miguel
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0117945 (2015)
The effect of local and systemic injections of mesenchymal stem cells derived from adipose tissue (AD-MSC) into rabbit models of corneal allograft rejection with either normal-risk or high-risk vascularized corneal beds was investigated. The models w
Externí odkaz:
https://doaj.org/article/57f03104c94942f1a4dcdbebf3f148f2
Autor:
Raquel García-Vílchez, Ana M. Añazco-Guenkova, Sabine Dietmann, Judith López, Virginia Morón-Calvente, Silvia D’Ambrosi, Paz Nombela, Kepa Zamacola, Isabel Mendizabal, Saioa García-Longarte, Amaia Zabala-Letona, Ianire Astobiza, Sonia Fernández, Alejandro Paniagua, Borja Miguel-López, Virginie Marchand, Diego Alonso-López, Angelika Merkel, Ignacio García-Tuñón, Aitziber Ugalde-Olano, Ana Loizaga-Iriarte, Isabel Lacasa-Viscasillas, Miguel Unda, Mikel Azkargorta, Félix Elortza, Laura Bárcena, Monika Gonzalez-Lopez, Ana M. Aransay, Tomás Di Domenico, Manuel A. Sánchez-Martín, Javier De Las Rivas, Sònia Guil, Yuri Motorin, Mark Helm, Pier Paolo Pandolfi, Arkaitz Carracedo, Sandra Blanco
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-36 (2023)
Abstract Newly growing evidence highlights the essential role that epitranscriptomic marks play in the development of many cancers; however, little is known about the role and implications of altered epitranscriptome deposition in prostate cancer. He
Externí odkaz:
https://doaj.org/article/23776f080b2242829817059af1fa8867
Autor:
Ignacio García-Tuñon, Elena Vuelta, Sandra Pérez-Ramos, Jesús M Hernández-Rivas, Lucía Méndez, María Herrero, Manuel Sanchez-Martin
Publikováno v:
Modulating Gene Expression-Abridging the RNAi and CRISPR-Cas9 Technologies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7a0ac8bf7831f2a0266623f2cb01117
https://doi.org/10.5772/intechopen.80245
https://doi.org/10.5772/intechopen.80245
Autor:
Tânia Albuquerque, Ana Raquel Neves, Milan Paul, Swati Biswas, Elena Vuelta, Ignacio García-Tuñón, Manuel Sánchez-Martin, Telma Quintela, Diana Costa
Publikováno v:
Journal of Functional Biomaterials, Vol 14, Iss 7, p 362 (2023)
The circadian clock controls behavior and physiology. Presently, there is clear evidence of a connection between this timing system and cancer development/progression. Moreover, circadian rhythm consideration in the therapeutic action of anticancer d
Externí odkaz:
https://doaj.org/article/f1614c48910e4ee1af46c4be82818902
Autor:
Miguel Quijada-Álamo, María Hernández-Sánchez, Ana-Eugenia Rodríguez-Vicente, Claudia Pérez-Carretero, Alberto Rodríguez-Sánchez, Marta Martín-Izquierdo, Verónica Alonso-Pérez, Ignacio García-Tuñón, José María Bastida, María Jesús Vidal-Manceñido, Josefina Galende, Carlos Aguilar, José Antonio Queizán, Isabel González-Gascón y Marín, José-Ángel Hernández-Rivas, Rocío Benito, José Luis Ordóñez, Jesús-María Hernández-Rivas
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 7, Pp 1-11 (2021)
Abstract BIRC3 is monoallelically deleted in up to 80% of chronic lymphocytic leukemia (CLL) cases harboring del(11q). In addition, truncating mutations in the remaining allele of this gene can lead to BIRC3 biallelic inactivation, which has been sho
Externí odkaz:
https://doaj.org/article/6298fa088832472aaa3af17d993dc8f6
Autor:
Lara Sánchez-Trujillo, Oscar Fraile-Martinez, Cielo García-Montero, Luis M. García-Puente, Luis G. Guijarro, Diego De Leon-Oliva, Diego Liviu Boaru, David Gardón-Alburquerque, María del Val Toledo Lobo, Mar Royuela, Ignacio García-Tuñón, Antonio Rios-Parra, Juan A. De León-Luis, Coral Bravo, Melchor Álvarez-Mon, Julia Bujan, Miguel A. Saez, Natalio García-Honduvilla, Miguel A. Ortega
Publikováno v:
Journal of Personalized Medicine, Vol 13, Iss 6, p 956 (2023)
Chronic venous disease (CVD) is a common condition that affects the veins in the lower limbs, resulting in a variety of symptoms, such as swelling, pain, and varicose veins (VVs). The plenty hormonal, hemodynamic and mechanical changes occurred in pr
Externí odkaz:
https://doaj.org/article/c460fdd5a3b14bba93fcd49438aa28e3
Autor:
Miguel A. Ortega, Diego De Leon-Oliva, Cielo Garcia-Montero, Oscar Fraile-Martinez, Diego Liviu Boaru, María del Val Toledo Lobo, Ignacio García-Tuñón, Mar Royuela, Natalio García-Honduvilla, Julia Bujan, Luis G. Guijarro, Melchor Alvarez-Mon, Miguel Ángel Alvarez-Mon
Publikováno v:
Genes, Vol 14, Iss 4, p 915 (2023)
Histone acetylation plays a vital role in organizing chromatin, regulating gene expression and controlling the cell cycle. The first histone acetyltransferase to be identified was histone acetyltransferase 1 (HAT1), but it remains one of the least un
Externí odkaz:
https://doaj.org/article/7cd011b7ed4b44f5a67aab56081b9021
Autor:
Elena Vuelta, José L. Ordoñez, David J. Sanz, Sandra Ballesteros, Jesús M. Hernández-Rivas, Lucía Méndez-Sánchez, Manuel Sánchez-Martín, Ignacio García-Tuñón
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 12, p 6386 (2022)
Chronic myeloid leukaemia (CML) is a haematological neoplasm driven by the BCR/ABL fusion oncogene. The monogenic aspect of the disease and the feasibility of ex vivo therapies in haematological disorders make CML an excellent candidate for gene ther
Externí odkaz:
https://doaj.org/article/15d472f820954c5fab3388e1d2d5c3e9
Autor:
Rodrigo Prieto-Bermejo, Marta Romo-González, Alejandro Pérez-Fernández, Ignacio García-Tuñón, Manuel Sánchez-Martín, Ángel Hernández-Hernández
Publikováno v:
Haematologica, Vol 106, Iss 1 (2020)
The regulation of protein function by reversible oxidation is increasingly recognized as a key mechanism for the control of cellular signaling, modulating crucial biological processes such as cell differentiation. In this scenario, NADPH oxidases mus
Externí odkaz:
https://doaj.org/article/ece7c130a93e41759a244432feea5802
Autor:
Adrián Montaño, Maribel Forero-Castro, Jesús-María Hernández-Rivas, Ignacio García-Tuñón, Rocío Benito
Publikováno v:
BMC Biotechnology, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Genome editing technologies offers new opportunities for tackling diseases such as acute lymphoblastic leukemia (ALL) that have been beyond the reach of previous therapies. Results We show how the recent availability of genome-edi
Externí odkaz:
https://doaj.org/article/e029ffe9b6844b939bf1ce04375e5895